Jeremy A. Dressler
Papers
1
Total Citations
69
H-Index
1
About
Dr. Jeremy A. Dressler is a leading figure in telestroke and acute stroke care, whose work has fundamentally reshaped how thrombolytic therapy is delivered in community settings. His landmark 2013 study, "Intravenous Tissue Plasminogen Activator Administration in Community Hospitals Facilitated by Telestroke Service," which has garnered 69 citations, provided critical evidence that intravenous tissue plasminogen activator (IV-tPA) could be administered safely and effectively in smaller hospitals when guided by remote specialists. This research directly addressed the stark reality that only 3.4%–5.2% of eligible stroke patients were receiving this life-saving treatment, demonstrating that telemedicine could bridge the expertise gap and dramatically expand access. Dr. Dressler’s contributions have been instrumental in validating telestroke networks as a standard of care, helping to reduce disability and mortality in underserved populations. His work continues to influence clinical guidelines and the design of regional stroke systems, cementing his reputation as a key innovator in the fight against one of the nation’s leading causes of death and disability.
Research Focus
Key Achievements
Top Papers
- 1